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Abstract
Purpose—To determine which nocturnal blood pressure (BP) parameters (low levels or extreme 
dipper status) are associated with an increased risk of glaucomatous damage in Hispanics.
Design—Observational cross-sectional study.
Correspondence: Gladys E. Maestre, MD, PhD, University of Texas Rio Grande Valley School of Medicine, Dept. of Biomedical 
Sciences, One West University Blvd. BROBL Rm. 106, Brownsville, TX 78520, Phone: 732-372-3378, Fax: 956-472-9974, 
gladys.maestre@utrgv.edu, gladysmaestre@gmail.com. 
Disclosure
None of the authors declare any conflicts of interest.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Ophthalmology. Author manuscript; available in PMC 2019 June 01.
Published in final edited form as:
Ophthalmology. 2018 June ; 125(6): 807–814. doi:10.1016/j.ophtha.2017.11.029.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Participants—A subset (n=93) of the participants from the Maracaibo Aging Study (MAS) who 
met the study eligibility criteria were included. These participants — who were at least 40 years of 
age — had measurements for optical tomography coherence, visual field tests, 24-hour BP, office 
BP, and intraocular pressure <22 mm Hg.
Methods—Univariate and multivariate logistic regression analyses under the generalized 
estimating equations (GEE) framework were used to examine the relationships between 
glaucomatous damage and BP parameters, with particular attention to drops in nocturnal BP.
Main Outcome Measures—Glaucomatous optic neuropathy (GON) based on the presence of 
optic nerve damage and visual field defects.
Results—The mean age was 61.9 years, and 87.1% were women. Of 185 eyes evaluated, 50 
(27.0%) had signs of GON. Individuals with GON had significantly lower 24-hour and nighttime 
diastolic BP levels than those without. However, results of the multivariate GEE models indicated 
that the glaucomatous damage was not related to the average systolic or diastolic BP levels 
measured over 24 hours, daytime, or nighttime. In contrast, extreme drops in nighttime systolic 
and diastolic BP (>20% compared with daytime BP) were significant risk factors for 
glaucomatous damage (odds ratio=19.78 and 5.55, respectively).
Conclusions—In this population, the link between nocturnal BP and GON is determined by 
extreme dipping effects rather than low nocturnal BP levels alone. Further studies considering 
extreme drops in nocturnal BP in individuals at high risk of glaucoma are warranted.
Graphical Abstract
In a Hispanic population-based cohort, the risk of glaucomatous optic neuropathy conferred by 
nocturnal blood pressure is explained by extreme dipping of diurnal systolic or diastolic blood 
pressure and not by blood pressure levels.
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Introduction
Glaucoma is an acquired and progressive optic neuropathy that is a leading cause of 
irreversible blindness worldwide.1 Identifying and controlling risk factors in the early stages 
of glaucomatous damage are important to preventing blindness. To date, elevated intraocular 
pressure (IOP) is the only modifiable risk factor proven to be effective in preventing and 
controlling glaucoma progression.1 However, glaucoma can develop and progress in eyes 
with IOP in the normal range.2 Thus, the identification of new modifiable risk factors could 
open new therapeutic approaches to glaucoma prevention and therapy.3
The role of systemic blood pressure (BP) in glaucoma pathogenesis has been increasingly 
gaining attention. However, its role based on conventional snapshot BP measurements of 
glaucomatous damage is unclear given the diurnal variations of BP.4–6 Twenty-four-hour 
ambulatory BP monitoring (ABPM) provides information on changes in BP during the day 
and at night, as well as mean BP levels. Studies using ABPM have suggested that nocturnal 
Melgarejo et al. Page 2
Ophthalmology. Author manuscript; available in PMC 2019 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hypotension is important to glaucoma progression4,7; it is unclear, however, which nocturnal 
BP parameter (low average nighttime BP vs. extreme dipper status) is the most relevant risk 
factor. Furthermore, previous studies using ABPM included only patients with 
glaucoma4,7–9; hence, it appears important to study the relationships between ABPM 
components and glaucoma risk in the general population.
The present study examined a subset of study participants from the Maracaibo Aging Study 
(MAS) to test the hypothesis that extreme dipper status (an exaggerated nighttime drop in 
systolic and/or diastolic BP), and not simply low average nighttime BP levels, contributes to 
glaucomatous optic neuropathy (GON).
Methods
Sample population
We studied 93 MAS participants who were evaluated for eye health and who met the 
selection criteria described below.10 The MAS — a population-based epidemiological study 
of age-related traits — currently includes approximately 3000 individuals, ≥40 years of age, 
living in the Santa Lucia neighborhood10 or in the nearby community of Santa Rosa de 
Agua11 in Maracaibo, Venezuela; all MAS participants received standardized assessments.10 
Randomly selected participants were invited to undergo an ophthalmological assessment. To 
be included in this study, individuals had to have completed optical tomography coherence 
(OCT) scans, visual field (VF) tests, ABPM, and office BP measurements. We decided to 
exclude one individual with an IOP ≥22 mm Hg, which we believed would only add 
uncertainty to results. Ninety-three individuals met the criteria. Each participant signed an 
informed consent, which was approved by the Institutional Review Boards of the 
Cardiovascular Institute at University of Zulia and Columbia University.
Ophthalmological assessment
Ophthalmologists conducted an ocular assessment of both eyes. This assessment included 
clinical ocular history; best-corrected visual acuity; a slit lamp examination (gonioscopy); 
and a dilated evaluation of the lens, vitreous, and retina. IOP was estimated with Goldmann 
tonometry. Standard automated perimetry was performed with the Heidelberg Edge 
Perimeter (Heidelberg Engineering, GmBH, Heidelberg, Germany). Spectralis spectral 
domain (SD)-OCT (software version 5.4.7.0; Heidelberg Engineering, GmBH) was used to 
measure the thickness of the peripapillary retinal nerve fiber layer (RNFL). Peripapillary 
RNFL measurements were obtained in a circle scan centered on the optic disc. The RNFL 
analysis used an automated computer algorithm to identify the anterior and posterior 
margins of the RNFL, from which the RNFL thickness was calculated. In addition, if the 
visual acuity was 20/20 or better in each eye according to the Standard Early Treatment 
Diabetic Retinopathy Study protocol at 4 m, refraction was the lensometer reading of the 
individual’s spectacle or plano. Otherwise, we performed a noncycloplegic autorefraction 
(Humphrey autorefractor model Hark 599, C. Zeiss, Meditec, Dublin). For individuals with 
visual acuity less than 20/20, subjective refraction was performed following standard 
protocols.
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Glaucomatous optic neuropathy diagnosis based on clinical examination and confirmation 
with SD-OCT abnormalities had to include at least two peripapillary sectors flagged as 
“borderline” (p <.05) or one sector “outside normal limits” (p <.01). All patients underwent 
clinical examination with indirect ophthalmoscopy with a 78/90 D lens. In addition, 
reflectance images of the optic disc were evaluated, looking for signs of cupping and RNFL 
thinning. Finally, the attending clinician and OCT/VF reader followed the recommendations 
of the American Academy of Ophthalmology Preferred Practice Patterns.12 OCT RNFL b-
scans had to be free of segmentation errors and blinking/eye movement artifacts. VF 
abnormalities required at least three neighboring points that were 5%, 5%, and 1% 
probability, or 5%, 2%, and 2% probability or poorer within a hemifield on pattern deviation 
plots, with only one point allowed on the edge of the visual field. VF results had false-
negative, false-positive, and fixation-loss rates less than 30%. Glaucoma was diagnosed 
during the clinical optic disc evaluation and was confirmed with SD-OCT peripapillary 
RNFL thickness measurements, based on the presence of GON and visual field 
abnormalities. Suspected glaucoma was diagnosed if the patient met the criteria for GON, 
but not for visual field abnormality. The ophthalmologist determined, via gonioscopy, that 
all cases of GON identified in our population were open-angle. An abnormal optic disc was 
defined as diffuse or focal narrowing, or notching, of the optic disc rim, or optic disc neural 
rim asymmetry of the two eyes consistent with loss of neural tissue. An abnormal VF, when 
present, was defined as 1) VF damage consistent with RNFL damage (e.g., nasal step, 
arcuate field defect, or paracentral depression in clusters of test sites) based on the presence 
of abnormal clusters; 2) VF defects consistent with glaucomatous optic nerve damage.
The diagnosis of glaucoma or suspected glaucoma was performed by one of the investigators 
(CGDM) from the Optic Nerve and Visual Field Reading Center at Columbia University 
Medical Center in New York. Due to the small number of individuals with glaucoma in the 
study, we combined the two diagnostic groups (i.e., glaucoma and suspected glaucoma) as 
the main outcome measure of glaucomatous optic neuropathy.
Blood pressure measurements
The office systolic BP and diastolic BP were obtained for each participant by trained nurses 
at the Cardiovascular Institute of the University of Zulia, using a validated automated device 
(Dynamap, XL). After participants had rested in a sitting position for 5 to 10 minutes, 5 
consecutive (one per minute) BP measurements were taken in a sitting position and 
averaged. ABPM devices (validated oscillometric 90202 or 90207 SpaceLabs monitors, 
Redmond, Washington) were programmed to obtain readings every 15 minutes during 
daytime hours (06:00–22:59) and every 30 minutes during nighttime (23:00–05:59).
The hypertension diagnosis followed the guidelines of the European Societies of Cardiology 
and Hypertension, 2013. Office hypertension was defined as systolic BP ≥140 mm Hg, 
diastolic BP ≥90 mm Hg, or use of antihypertensive drugs. The 24-hour BP, daytime BP, and 
nighttime BP measurements were the average BP recordings during the appropriate 
intervals. Ambulatory hypertension was defined as 24 hours of systolic BP ≥130, diastolic 
BP ≥80 mm Hg, or the use of antihypertensive drugs.
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Dipper statuses were defined as follows: (i) extreme dipper: an abnormal decrease in the 
nocturnal BP levels more than 20% in relation to diurnal BP levels; (ii) dipper: a normal 
decrease in the nocturnal BP levels between 20% and 10% in relation to diurnal BP levels; 
(iii) nondipper: a minor or no decrease in nocturnal BP levels, ranging from 10% to 0%; and 
finally (iv) reverse dipper: an abnormal increase in nocturnal BP levels in relation to daytime 
BP levels. To identify the decrease or increase in nocturnal BP levels in relation to daytime 
BP levels, we used the ABPM to calculate the night/day BP ratio, as suggested by Fagard 
and colleagues.13 Night/day BP ratios ≤0.8 indicated an extreme dipper, >0.8 to 0.9 
indicated a dipper, >0.9 to 1.0 indicated a nondipper, and >1.0 indicated a reverse dipper. 
Dipper status was determined separately for systolic BP and diastolic BP. We combined 
reverse dippers with nondippers for analysis due to the small number of participants who 
were reverse dippers, and the fact that nondipper and reverse dipper status did not add any 
significant risk for GON (Table S1).
Other information
Participants provided their medical history, including age, sex, level of education, smoking 
history, alcohol intake, and antihypertensive drug treatment. In addition, clinical and 
laboratory assessments were performed to measure total cholesterol, LDL cholesterol, 
triglycerides, and HbA1c. Body mass index (BMI) was calculated by kg/m2. Diabetes 
mellitus was defined as a glucose serum level ≥126 mg/dl, HbA1c ≥6.5%, or intake of anti-
diabetic drugs.
Statistical analyses
Categorical variables were compared for the two groups using the chi-squared test, and 
continuous variables were compared using Student’s t-test. To assess various BP parameters 
as risk factors for glaucomatous damage, we performed univariate and multivariate logistic 
regression analyses under the generalized estimating equations (GEE) framework to take 
into account nonindependence of the two eyes within an individual. Confounders were 
identified using a threshold of p <.1 in the comparison of baseline characteristics. However, 
despite the p value, the IOP was selected as a confounder due to its alluded role in the 
pathogenesis of GON. One multivariate model was adjusted only for age, and another model 
was fully adjusted for age, education level, BMI, LDL-cholesterol, creatinine, conventional 
hypertension, refractive error and IOP. All the analyses were performed using SPSS 23 (IBM 
Corp.). Statistical significance was accepted at p <.05 for two-tailed tests.
Results
Sample Population
The mean age of the participants was 61.9 years, and 87.1% were women (Table 1). Some 
28.0% were smokers and 9.7% reported consuming alcohol. Approximately 14.0% had 
diabetes. The prevalence of hypertension based on office BP and ABPM were 64.5% and 
55.9%, respectively, and 47.3% of those with office hypertension were taking anti-
hypertensive medications. Table S1 shows the comparison of the baseline characteristics 
between nonincluded and included individuals. Nonincluded individuals in the present study 
were older, were less frequently women, had fewer years of education, were more often 
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smokers, had a higher proportion of alcohol intake, had a lower BMI, were more like to have 
hypertension, had lower levels of LDL cholesterol, had a history of cardiovascular diseases, 
had poorer treatment of hypertension, and had higher levels of conventional and ambulatory 
BP.
Of the 93 participants, 26 (30.0%) had at least one eye with GON (Table 1). A total of 185 
eyes were evaluated, and 49 (26.6%) were identified as having GON: 19 (10.3%) as 
glaucoma and 30 (16.1%) as suspected glaucoma. One individual with an IOP ≥22 mm Hg 
in one eye was excluded from the analysis. Individuals with GON were significantly older, 
had lower levels of education, a lower BMI, and were more likely to have refractive errors 
than individuals with healthy eyes. The type of anti-hypertensive treatment was not 
associated with GON (Table S3).
Blood Pressure Levels and Glaucomatous Eyes
Office systolic BP levels were significantly higher in participants with GON than in 
individuals with healthy eyes (Table 2). In contrast, systolic BP levels based on 24-hour 
ABPM did not differ between GON and healthy eyes, but levels of diastolic BP, especially 
nighttime diastolic BP, were significantly lower in individuals with GON when compared 
with BP levels in those with healthy eyes. However, the two multivariate adjusted GEE 
models showed levels of diastolic BP were no longer significantly associated with 
glaucomatous damage (Table 3).
Dipper Status and Glaucomatous Risk
We then further examined 24-hour BP by determining whether BP dipper status influenced 
GON. When the proportions of extreme dippers were compared between individuals with 
GON eyes vs. healthy eyes, 18.4% of the glaucomatous eyes had extreme dipper status by 
systolic BP, whereas just 3.0% of the healthy eyes did. Similarly, 34.7% of the glaucomatous 
eyes had extreme dipper status by diastolic BP, whereas 17.8% of the healthy eyes did 
(Figure 1). Under the fully adjusted multivariate GEE models, extreme dippers (systolic and 
diastolic) had a significantly higher risk of having glaucomatous eyes when compared with 
normal dippers (Table 4). Meanwhile, non-dipper and reverse dipper effects were not 
associated with an increased risk of GON.
Discussion
The present study suggests that the extreme drop in BP as defined by a decrease >20% of 
nocturnal BP levels compared with daytime BP levels, rather than nocturnal hypotension per 
se, increases glaucoma risk. Individuals with low nighttime BP levels did not show elevated 
risk. Overall, our study demonstrated that after adjusting for confounders, systolic BP and 
diastolic BP levels, averaged for 24-hour, daytime, and nighttime intervals were not 
significant risk factors for presence of GON, whereas either extreme dipper systolic and 
diastolic status were associated with increased risk of GON.
The rates of glaucoma (10.3%), suspected glaucoma (16.1%), and GON (26.6%) were high 
in our study in contrast with Black-Hispanics living in Barbados6, or Mexican-Americans 
living in Los Angeles14 or Arizona,15 but were similar to rates of suspected glaucoma 
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among Hispanics of Caribbean origin residing in New York16. Populations from Maracaibo 
have a proportion of ancestral European, African, and Native American genetic 
contributions that have more in common with other Caribbean populations than with 
Mexican populations17, which could explain the different proportion of individuals with 
glaucomatous damage. In addition, environmental exposures might explain the high rates of 
GON in the MAS population, including low socioeconomic status and the low Human 
Development Index that characterize this population.18 On the other hand, of particular 
importance for glaucoma risk is the high prevalence and low treatment and control rates of 
hypertension among the studied population.18
The relationship between systemic BP levels and glaucoma pathogenesis has been 
extensively examined, and nocturnal hypotension is known to be a major risk factor for the 
prognosis and progression of glaucoma diseases.7,8,19,20 The proposed mechanism 
implicated is chronic ischemia.19,20 When BP levels decrease sharply during the night, 
systemic perfusion of the eye is inadequate.20–22 Autoregulation of eye circulation can 
normalize the perfusion, but autoregulation might be compromised in individuals with 
glaucoma. In those individuals, the extreme reduction of perfusion pressure in the optic 
nerve head can lead to ischemia and, ultimately, to GON.19 Interestingly, low nighttime BP 
levels were not significantly associated with glaucomatous damage unless there was an 
extreme dipping effect.
Approximately 15%–25% of individuals aged ≥40 years have an extreme dipper pattern, 
which has been linked to increased duration of heart ischemic episodes, cognitive decline, 
and silent brain infarction.23,24 Furthermore, extreme dipping status is associated with 
progression of glaucoma.20,25 Our study extends these findings in that (i) individuals with 
extreme dipping effect exhibited the highest increased risk for GON; (ii) our results were 
determined in the general Hispanic population.
Our study showed that nocturnal BP measurements as measured by ABPM are more 
insightful indicators of glaucomatous damage than one-time measurements of office BP. 
Previous studies similarly found that ABPM is a reliable predictor of hypertensive 
retinopathy, diabetic retinopathy, macular alterations, VF defects, and glaucoma.26–28 
ABPM is also a better predictor of risk to other organs,29,30 including chronic kidney 
disease, stroke, and cardiac events.31,32 However, our study is the first to compare ABPM 
and office BP as indicators of glaucoma risk in the general population, and it suggests that 
measures from ABPM can be considered as a useful tool for clinicians to identify at-risk 
individuals long before symptoms of glaucomatous damage appear.
IOP was not found to be a risk factor for GON in our study. The role of IOP as a risk factor 
for glaucoma in normotensive eyes is well-established.33 Specifically, studies have attributed 
IOP to the progression of glaucomatous damage (as visual field defect progression or 
increased cup disc ratio).33 Given we were unable to follow up, we could not establish 
whether IOP is related to progression of GON in our study. On the other hand, in contrast 
with other population-based studies5,34,35, our IOP average (12.7±3.0 mm Hg for total 
population; 13.3±3.6 for GON; and 12.4±2.8 for healthy eyes) is lower; 14.4±3.5 mm Hg,5 
14.6±3.1 mm Hg,34 and 14.7±2.4 mm Hg, respectively (among individuals 40–49 years of 
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age).35 The discrete difference of IOP between our sample and other studies might not 
provide a reliable explanation supporting that IOP is not a risk factor in our population; 
however, there is evidence suggesting that the relationship between IOP and GON is 
astonishingly weak, especially at the lower end of IOP levels, indicating that other risk 
factors are involved in GON.36 Extrapolating that argument, our mean IOP is nearer to the 
lower limit of IOP (10 mm Hg) than the average mean of the other studies. Thus, we suggest 
that IOP has less impact on GON in our population sample than in other population-based 
studies.
The main limitation of the study is the small sample size that precludes us from comparing 
extreme dipper status as a risk factor for glaucomatous damage in individuals with normal 
vs. low average nighttime BP, and from comparing the risk of individuals exhibiting non-
dipper and reverse dipper status vs. dippers. In addition, the combined analyses of glaucoma 
and suspected glaucoma might hinder specific associations related to glaucoma. However, 
there is sufficient overlap between suspected glaucoma and early glaucoma to suggest that 
their shared elements are substantial and are worth detecting. Another aspect that needs to be 
clarified is whether risk factors for extreme dipper status, such as physical activity,37 sleep 
quantity and quality,38 and timing of antihypertensive medications39 are more closely 
associated with GON than extreme dipper status. Lastly, although we measured conventional 
BP in a sitting position, we were not able to control the positional changes during ABPM 
recordings. This note is relevant because positional changes are linked with changes in BP 
levels. We hope to examine that issue in the future.
In summary, our results support the hypothesis that the association between nocturnal 
hypotension and GON is determined by having extreme dipping effect and not by low 
average nighttime BP levels. Further studies examining the progression to glaucoma in 
individuals identified as high risk would clarify the usefulness of extreme dipper status as a 
risk factor. Our results support the use of ABPM to help identify individuals with extreme 
dipper status who are at high risk of GON and who should undergo further ophthalmological 
assessment. Therapies that modify glaucoma risk are urgently needed, and new approaches 
to avoiding the extreme dipper effect, such as changes in the timing of antihypertensive drug 
intake, might be effective.
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ABPM ambulatory blood pressure monitoring
BMI body mass index
BP blood pressure
GEE generalized estimating equations
GON glaucomatous optic neuropathy
MAS Maracaibo Aging Study
OCT optical coherence tomography
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Figure 1. 
Proportion of dipper status in healthy and glaucomatous eyes.
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Table 1
Baseline Characteristics of the Total Population, Stratified by Individuals with Glaucomatous Optic 
Neuropathy and Healthy Eyes
Baseline characteristics
Total population (n = 
93)
Individuals with 
Glaucomatous Optic 
Neuropathy* (n = 26)
Individuals with Healthy 
eyes (n = 67) p value†
Age, years 61.9±13.3 70.9±12.1 58.4±12.1 <0.001
Women, n (%) 81 (87.1) 23 (88.5) 58 (86.6) 0.807
Education, years 7.6±5.0 5.4±3.4 8.4±5.3 0.009
History of smoking, n (%) 26 (28.0) 9 (34.6) 17 (25.4) 0.373
Alcohol intake, n (%) 9 (9.7) 3 (11.5) 6 (9.0) 0.705
Body mass index, 28.2±5.1 26.5±6.0 28.8±4.7 0.007
Diabetes mellitus, n (%) 13 (14.0) 5 (19.2) 8 (11.9) 0.363
Total Cholesterol, mg/dl 196.8±46.9 188.3±47.6 199.7±46.6 0.325
LDL cholesterol, mg/dl 125.5±53.8 109.3±42.1 131.0±56.4 0.100
HDL cholesterol, mg/dl 44.1±11.4 46.3±9.9 43.4±11.8 0.299
Triglycerides, mg/dl 140.8±81.0 130.0±83.3 144.5±80.6 0.471
Creatinine, mg/dl 0.9±0.3 1.0±0.3 0.8±0.2 0.066
HbA1c, % 5.8±0.7 5.8±0.4 5.7±0.5 0.513
Conventional hypertension, n (%) 60 (64.5) 20 (76.9) 40 (57.7) 0.119
Ambulatory hypertension, n (%) 52 (55.9) 16 (61.5) 36 (53.7) 0.496
Antihypertensive treatment, n (%)‡ 44 (47.3) 14 (53.8) 30 (44.8) 0.432
Refractive Errors, n (%) 38 (40.9) 15 (57.7) 23 (34.3) 0.040
IOP, mmHg 12.7±3.0 13.3±3.6 12.4±2.8 0.199
Proportion of glaucoma diagnosis cases = suspected glaucoma 30 (16.2%); glaucoma 20 (10.8%); and glaucomatous optic neuropathy 50 (27.0%).
LDL= low-density lipoprotein; HDL= high-density lipoprotein; IOP= intraocular pressure.
*Among those 26 individuals with glaucomatous optic neuropathy, 30 (16.1%) eyes had suspected glaucoma while 19 (10.3%) eyes had glaucoma. 
A total of 49 (26.6%) eyes were identified as eyes with glaucomatous optic neuropathy.
†p value of the baseline comparison between individuals with glaucomatous optic neuropathy and healthy eyes.
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Table 2
Distribution of Blood Pressure Levels in the Total Population and Between Individuals with Glaucomatous 
Optic Neuropathy and with Healthy Eyes
Total population (n = 93)
Individuals with Glaucomatous Optic 
Neuropathy* (n = 26)
Individuals with Healthy eyes (n 
= 67) p value*
Conventional BP
 Systolic BP 141.0±22.8 148.7±26.1 138.0±20.8 0.041
 Diastolic BP 76.0±8.3 74.4±10.0 76.6±7.5. 0.247
Ambulatory BP
 24-hour BP
  Systolic BP 122.2±15.0 121.9±17.4 122.3±14.2 0.911
  Diastolic BP 70.4±8.5 67.0±8.5 71.8±8.2 0.014
 Daytime BP
  Systolic BP 123.7±14.2 124.1±17.1 123.5±13.1 0.847
  Diastolic BP 72.1±8.5 69.3±8.9 73.1±8.2 0.053
 Nighttime BP
  Systolic BP 118.0±18.6 116.8±20.5 118.4±18.0 0.722
  Diastolic BP 66.0±10.0 61.7±9.8 67.6±9.6 0.009
BP= blood pressure; MAP = mean arterial pressure.
*p value of the blood pressure comparison between individuals with glaucomatous and healthy eyes.
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Table 3
Multivariate Logistic Regression Analysis Using the General Estimating Equation to Determine the 
Association Between Blood Pressure Levels and Glaucomatous Optic Neuropathy
Office and ambulatory blood pressure
Risk Estimate for Glaucomatous Optic Neuropathy
Adjusted* Fully-adjusted†
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Conventional BP
 Systolic BP 1.00 (0.98–1.02) 0.831 1.00 (0.98–1.02) 0.913
 Diastolic BP 0.98 (0.92–1.06) 0.652 0.99 (0.92–1.06) 0.724
Ambulatory BP
 24-hour BP
  Systolic BP 0.99 (0.96–1.02) 0.390 0.99 (0.96–1.02) 0.541
  Diastolic BP 0.96 (0.89–1.02) 0.192 0.96 (0.90–1.03) 0.221
 Day-time BP
  Systolic BP 0.99 (0.96–1.03) 0.674 1.00 (0.96–1.03) 0.858
  Diastolic BP 0.98 (0.92–1.04) 0.425 0.98 (0.92–1.04) 0.490
 Nighttime BP
  Systolic BP 0.98 (0.95–1.01) 0.221 0.99 (0.96–1.01) 0.305
  Diastolic BP 0.95 (0.89–1.01) 0.089 0.95 (0.89–1.01) 0.101
BP= blood pressure; CI = confidence interval; MAP = mean arterial pressure.
*
Model adjusted by age.
†
Fully adjusted, was performed by age, education, body mass index, creatinine, refractive error and IOP.
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Table 4
Multivariate Logistic Regression Analysis Using the General Estimating Equation to Determine the 
Association Between Dipper Status and Glaucomatous Optic Neuropathy
Risk Estimate for Glaucomatous Optic Neuropathy
Dipper Status
Adjusted* Fully-adjusted†
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Model 1
 Systolic dipper status#
  Extreme dipper 9.44 (1.70–52.2) 0.010 19.78 (2.23–175.50) 0.007
  Dipper 1.00 (Reference) 1.00 (Reference)
  Non-dipper and reverse dipper 0.63 (0.21–1.90) 0.411 1.62 (0.50–5.54) 0.446
Model 2
 Diastolic dipper status#
  Extreme dipper 4.64 (1.34–16.1) 0.016 5.55 (1.04–29.62) 0.045
  Dipper 1.00 (Reference) 1.00 (Reference)
  Non-dipper and reverse dipper 1.02 (0.30–3.38) 0.980 0.90 (0.30–3.01) 0.860
OD = odds ratio; CI = confidence interval; IOP = intraocular pressure; MAP = mean arterial pressure.
*
Model adjusted by age.
†
Fully adjusted, was performed by age, education, body mass index, creatinine, refractive error and IOP.
#
Dipper status follows the definition of Fagard et al.,15 in which night/day BP ratios ≤0.8 indicated extreme dipper, >0.8 to 0.9 indicated dipper, 
>0.9 to 1.0 indicated non-dipper and >1.0 indicated reverse dipper.
Ophthalmology. Author manuscript; available in PMC 2019 June 01.
